Biological Changes in Fibrovascular Membranes of Patients With Proliferative Diabetic Retinopathy Following Faricimab Injection

NCT07144865 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Proliferative Diabetic Retinopathy

Interventions

DRUG: conbercept ophthalmic injection （0.5mg）
DRUG: Faricimab

Sponsor

Bojie Hu